Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Esophageal Neoplasms

phorbol 12,13-dibutyrate has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carballo, M; Maish, MS; Yetasook, A	1

Other Studies

1 other study(ies) available for phorbol 12,13-dibutyrate and Esophageal Neoplasms

Article	Year
Phorbol 12,13 dibutyrate behaves in a tumor-inhibitory manner in esophageal adenocarcinoma cell lines. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2011, Volume: 24, Issue:8 Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Humans; Oncogene Protein v-akt; Phorbol 12,13-Dibutyrate; Phosphorylation; Protein Kinase C; Signal Transduction	2011

Article

Year

Phorbol 12,13 dibutyrate behaves in a tumor-inhibitory manner in esophageal adenocarcinoma cell lines.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2011, Volume: 24, Issue:8

Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Humans; Oncogene Protein v-akt; Phorbol 12,13-Dibutyrate; Phosphorylation; Protein Kinase C; Signal Transduction

2011